Removal of the aniline 4′-NO2 group diminished DNA breaks and chromosomal damage induced by niclosamide while enhancing its selectivity against p53-deficient cancer cells, using isogenic human colorectal HCT116 p53+/+ and p53−/− cancer cells as a study model. The gene discussed is TP53; the disease is cancer.